[Retracted] High Inflammatory Factor Levels Increase Cardiovascular Complications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting
Table 1
Baseline data of patients.
Item
Overall ()
Non-MACCE group ()
MACCE group ()
value
Gender (male/female)
214/86
196/72
18/14
0.046
Age (years)
0.680
BMI (kg/m2)
0.001
Smoking (%)
151 (50.3)
128 (47.8)
23 (71.9)
0.010
Medical history
Hypertension (%)
215 (71.7)
194 (72.4)
21 (65.6)
0.422
Hyperlipidemia (%)
183 (61.0)
157 (58.6)
26 (81.3)
0.013
COPD (%)
13 (4.3)
11 (4.1)
2 (6.3)
0.573
Myocardial infarction (%)
93 (31.0)
83 (31.0)
10 (31.3)
0.974
Family history of coronary heart disease (%)
75 (25.0)
67 (25.0)
8 (25.0)
—
History of unstable angina (%)
114 (38.0)
99 (36.9)
15 (46.9)
0.274
Congestive heart failure (%)
34 (11.3)
30 (11.2)
4 (12.5)
—
Duration of diabetes (years)
0.001
NYHA grading
0.754
I~II grade(%)
272 (90.7)
242 (90.3)
30 (93.8)
≥III grade (%)
28 (9.3)
26 (9.7)
2 (6.3)
GRACE risk classification
0.725
Level 1 (%)
185 (61.7)
165 (61.6)
20 (62.5)
Level 2 (%)
96 (32.0)
87 (32.5)
9 (28.1)
Level 3 (%)
19 (6.3)
16 (6.0)
3 (9.4)
Creatinine (μmol/L)
0.797
Medication
RAAS blocker
146 (48.7)
131 (48.9)
15 (46.9)
0.830
Antiplatelet drug (%)
195 (65.0)
175 (65.3)
20 (62.5)
0.754
β-Blocker (%)
130 (43.3)
117 (43.7)
13 (40.6)
0.744
Calcium antagonists (%)
88 (29.3)
80 (29.9)
8 (25.0)
0.569
Diuretics (%)
62 (20.7)
55 (20.5)
7 (21.9)
0.858
Insulin (%)
78 (26.0)
69 (25.7)
9 (28.1)
0.772
Data are presented as or (%). indicated that the difference was statistically significant. Non-MACCE: no cardiovascular event group; MACCE: cardiovascular event group: COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; GRACE Risk Classification: Global Registry of Acute Coronary Events.
